This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Volastra Therapeutics, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Rutger Folmer
Introduction
Rutger Folmer is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for specific enzymes. His work is characterized by a focus on innovative solutions for treating diseases.
Latest Patents
Rutger Folmer holds a patent for "Imino sulfanone inhibitors of ENPP1." This patent relates to inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), along with the compositions and methods of using these compounds. More specifically, the patent discusses sulfoximine-based inhibitors of ENPP1 and their potential applications in treating diseases mediated by this enzyme. He has 1 patent to his name.
Career Highlights
Rutger is currently associated with Volastra Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative therapeutic solutions that address critical health challenges.
Collaborations
Rutger has collaborated with several talented individuals in his field, including Sarah Bettigole and Leon Van Berkom. These collaborations have contributed to the advancement of his research and the development of new therapeutic strategies.
Conclusion
Rutger Folmer's contributions to the field of medicinal chemistry and his innovative patent on ENPP1 inhibitors highlight his role as a significant inventor. His ongoing work at Volastra Therapeutics, Inc. continues to pave the way for advancements in disease treatment.